Cytokinetics, Inc. (CYTK) Reports In-Line Q2 Loss of 13c/Share
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $73.25 -0.27%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13).
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
